江西赣南海欣药业股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
130
NMPA:130
Drug Approvals
Dexmedetomidine Hydrochloride Injection
- Product Name
- 盐酸右美托咪定注射液
- Approval Number
- 国药准字H20253292
- Approval Date
- Jan 24, 2025
NMPA
Dexmedetomidine Hydrochloride Injection
- Product Name
- 盐酸右美托咪定注射液
- Approval Number
- 国药准字H20253293
- Approval Date
- Jan 24, 2025
NMPA
Famotidine for Injection
- Product Name
- 注射用法莫替丁
- Approval Number
- 国药准字H20083912
- Approval Date
- Dec 16, 2023
NMPA
Azithromycin for Suspension
- Product Name
- 阿奇霉素干混悬剂
- Approval Number
- 国药准字H20093669
- Approval Date
- Nov 2, 2023
NMPA
Troxerutin for Injection
- Product Name
- 注射用曲克芦丁
- Approval Number
- 国药准字H20041707
- Approval Date
- Aug 10, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 13
- Next
Clinical Trials
No trials found
News
No news found